Your browser doesn't support javascript.
loading
Effect of donor characteristics on T cell-replete haploidentical stem cell transplantation over the last 10 years at a single institution.
Wu, Yibo; Lai, Xiaoyu; Shi, Jimin; Tan, Yamin; Zhao, Yanmin; Yu, Jian; Liu, Lizhen; Zhang, Wei; Huang, He; Luo, Yi.
Afiliação
  • Wu Y; Bone Marrow Transplantation Center, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • Lai X; Institute of Hematology, Zhejiang University, Hangzhou, China.
  • Shi J; Zhejiang Province Engineering Laboratory for Stem Cell and Immunity Therapy, Hangzhou, China.
  • Tan Y; Liangzhu Laboratory, Zhejiang University Medical Center, Hangzhou, China.
  • Zhao Y; Bone Marrow Transplantation Center, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • Yu J; Institute of Hematology, Zhejiang University, Hangzhou, China.
  • Liu L; Zhejiang Province Engineering Laboratory for Stem Cell and Immunity Therapy, Hangzhou, China.
  • Zhang W; Liangzhu Laboratory, Zhejiang University Medical Center, Hangzhou, China.
  • Huang H; Bone Marrow Transplantation Center, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • Luo Y; Institute of Hematology, Zhejiang University, Hangzhou, China.
Br J Haematol ; 196(5): 1225-1238, 2022 03.
Article em En | MEDLINE | ID: mdl-34859418
ABSTRACT
One of the most complex issues with haploidentical stem cell transplantation (haplo-SCT) is donor selection, given that multiple haploidentical donors are often available for a given recipient. To develop evidence-based guidance for donor selection in the setting of anti-thymocyte globulin-based haplo-SCT, we performed a prospective cohort study of 512 patients with haematological malignancies who had haplo-SCT to determine which donor variables were most important in favouring transplant outcomes. Increasing donor age was associated with poorer overall survival (OS) [hazard ratio (HR) 1·08, P = 0·044]. Female donors to male recipients was significantly associated with higher non-relapse mortality (NRM; HR 2·05, P = 0·006). Furthermore, increasing donor age had a higher risk of Grades 3-4 acute graft-versus-host disease (aGVHD; HR 1·17, P = 0·005), female donors to male recipients was associated with a higher risk of Grades 2-4 aGVHD (HR 1·50, P = 0·022). Sibling donors had superior OS, disease-free survival, and NRM than parental donors in patients aged <35 years. However, sibling donors had higher NRM than offspring donors in patients aged ≥35 years. A younger donor, usually a young sibling in younger recipients (aged <35 years) or a young offspring in older patients (aged ≥35 years) and avoiding female donors to male recipients should be preferred when multiple haploidentical donors are available.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transplante de Células-Tronco Hematopoéticas / Seleção do Doador / Transplante Haploidêntico Tipo de estudo: Etiology_studies / Observational_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transplante de Células-Tronco Hematopoéticas / Seleção do Doador / Transplante Haploidêntico Tipo de estudo: Etiology_studies / Observational_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male Idioma: En Ano de publicação: 2022 Tipo de documento: Article